Bioorganic and Medicinal Chemistry Letters p. 1791 - 1796 (1998)
Update date:2022-09-26
Topics:
Chambers
Antognoli
Cheng
Marfat
Pillar
Shirley
Watson
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
View MoreGuilin Zhenda Bio-Tech Co., Ltd.
Contact:86-773-3568977
Address:-Yangtang shangshui industry park, Lingui county,
SHIFANG SUHONG CHEMICAL CO.,LTD
Contact:+86-838-2224563
Address:Room 1207 Zongchen Sunshine No.128 Taishan South Road,Deyang City,Sichuan China
Golden Union Agrochemical Import and Export Co., Ltd.
Contact:86-755-23910527
Address:Room 1106, Tower 3A, Excellence Century Center, Futian District, Shenzhen, China
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
Doi:10.1016/S0040-4039(97)01002-2
(1997)Doi:10.1039/a807718e
(1999)Doi:10.1002/hlca.19970800424
(1997)Doi:10.1021/acs.organomet.7b00603
(2018)Doi:10.1016/S0040-4020(97)00526-7
(1997)Doi:10.1021/jo970548x
(1997)